Complete Filing Data
X4 Pharmaceuticals, Inc reported Stockholders Equity of $186.29 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean X4 Pharmaceuticals, Inc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$79.2M | -$37.5M | -$101.2M | -$93.9M | -$88.7M | -$62.1M | -$52.8M | -$33.3M | -$22.0M | -$23.0M |
| Revenue * | $35.1M | $2.6M | $0.00 | $0.00 | $0.00 | $3.0M | $0.00 | $0.00 | ||
| Research And Development Expense | $72.7M | $81.6M | $72.0M | $61.1M | $50.6M | $41.9M | $30.2M | $20.3M | $17.1M | $17.8M |
| Operating Income Loss | -$86.9M | -$36.4M | -$107.5M | -$87.6M | -$85.1M | -$59.9M | -$51.7M | -$29.1M | -$22.2M | -$24.3M |
| Nonoperating Income Expense | $7.7M | -$739.0K | $6.4M | -$6.3M | -$3.6M | -$2.1M | -$1.1M | -$4.2M | $253.0K | $1.4M |
| General And Administrative Expense | $43.5M | $61.5M | $35.5M | $27.0M | $24.7M | $20.9M | $17.6M | $8.7M | $5.2M | $6.5M |
| Other Nonoperating Income Expense | -$753.0K | $332.0K | $554.0K | -$4.2M | $426.0K | $905.0K | $517.0K | $0.00 | $0.00 | $104.0K |
| Operating Expenses | $107.5M | $87.6M | $85.1M | $62.9M | $51.7M | $29.1M | $22.2M | $24.3M | ||
| Interest Expense | $5.8M | $4.0M | $3.6M | $2.7M | $2.1M | $720.0K | $490.0K | $2.5M | ||
| Net Income Loss Available To Common Stockholders Basic | -$37.5M | -$101.2M | -$96.4M | -$102.6M | -$62.1M | -$53.4M | -$36.3M | -$25.0M | -$23.0M | |
| Income Tax Expense Benefit | $41.0K | $310.0K | $78.0K | $28.0K | $17.0K | $148.0K | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$79.2M | -$37.1M | -$101.1M | -$93.8M | -$88.7M | -$62.0M | -$52.8M | -$33.3M | ||
| Non Cash Interest Expense | $865.0K | $856.0K | $929.0K | $918.0K | $756.0K | $532.0K | $695.0K | $152.0K | $157.0K | $2.3M |
| Research And Development Incentive Receivable | $0.00 | $640.0K | $562.0K | $1.2M | $747.0K | $917.0K | $2.0M | $0.00 | ||
| Comprehensive Income Net Of Tax | -$37.5M | -$101.2M | -$93.9M | -$88.7M | -$62.1M | -$52.9M | -$33.3M | -$22.0M | -$22.9M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$3.0K | $0.00 | $0.00 | $0.00 | $0.00 | -$119.0K | $0.00 | $0.00 | $116.0K | |
| Cost Of Revenue | $5.8M | $797.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$29.8M | -$25.7M | $282.0K | -$36.7M | $90.8M | -$51.8M | -$2.3M | -$55.7M | -$24.0M | -$21.6M | -$21.2M | -$22.0M | -$20.2M | -$19.6M | -$18.7M | -$17.4M | -$15.1M | -$11.1M | -$17.7M | -$13.4M | -$10.9M | -$9.4M | -$8.6M | -$6.0M | -$7.4M | -$11.2M | -$11.6M | -$5.7M | -$5.4M | |
| Revenue * | $1.8M | $2.0M | $28.8M | $560.0K | $563.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.0M | $0.00 | $0.00 | $0.00 | $3.5M | ||||||||||||
| Research And Development Expense | $17.3M | $18.4M | $18.5M | $19.2M | $20.9M | $19.9M | $19.1M | $15.6M | $22.1M | $14.1M | $13.8M | $14.1M | $13.2M | $13.2M | $12.1M | $11.4M | $9.3M | $8.9M | $8.6M | $8.9M | $5.7M | $6.2M | $4.8M | $4.7M | $10.6M | $3.9M | $4.4M | |||
| Operating Income Loss | -$27.5M | -$26.2M | -$9.4M | -$34.5M | $71.1M | -$37.3M | -$27.2M | -$25.8M | -$29.3M | -$20.2M | -$20.6M | -$21.3M | -$19.1M | -$19.0M | -$17.9M | -$17.0M | -$14.7M | -$10.6M | -$17.0M | -$13.4M | -$10.4M | -$8.5M | -$6.4M | -$6.1M | -$13.1M | -$5.6M | -$5.8M | |||
| Nonoperating Income Expense | -$2.3M | $528.0K | $9.8M | -$2.2M | $19.7M | -$14.5M | $24.9M | -$29.9M | $5.3M | -$1.4M | -$638.0K | -$674.0K | -$1.1M | -$635.0K | -$734.0K | -$469.0K | -$486.0K | -$409.0K | -$738.0K | $31.0K | -$435.0K | -$57.0K | $342.0K | -$1.3M | $1.5M | -$61.0K | $442.0K | |||
| General And Administrative Expense | $11.6M | $9.5M | $15.0M | $15.7M | $13.3M | $17.4M | $8.1M | $10.2M | $7.2M | $6.0M | $6.7M | $7.7M | $5.9M | $5.8M | $5.8M | $5.6M | $5.3M | $4.7M | $4.4M | $4.6M | $4.8M | $2.4M | $1.6M | $1.4M | $2.5M | $1.7M | $1.4M | |||
| Other Nonoperating Income Expense | -$304.0K | -$547.0K | $105.0K | $700.0K | $226.0K | $144.0K | $105.0K | $17.0K | $202.0K | $123.0K | -$441.0K | -$59.0K | $60.0K | -$74.0K | $210.0K | $186.0K | $228.0K | $194.0K | $41.0K | $52.0K | $149.0K | $0.00 | $0.00 | $1.0K | -$74.0K | $86.0K | -$28.0K | -$1.0K | ||
| Operating Expenses | $37.3M | $27.2M | $25.8M | $29.3M | $20.2M | $20.6M | $21.3M | $19.1M | $19.0M | $17.9M | $17.0M | $14.7M | $13.6M | $17.0M | $13.4M | $10.4M | $13.0M | $8.5M | $6.4M | $6.1M | $11.6M | $13.1M | $5.6M | $5.8M | ||||||
| Interest Expense | $2.4M | $2.2M | $1.9M | $1.6M | $1.1M | $1.1M | $1.0M | $918.0K | $913.0K | $920.0K | $905.0K | $891.0K | $697.0K | $687.0K | $584.0K | $688.0K | $512.0K | $399.0K | $148.0K | $167.0K | $169.0K | $343.0K | $444.0K | $1.0M | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$2.3M | -$55.7M | -$24.0M | -$21.9M | -$21.2M | -$24.2M | -$20.2M | -$19.6M | -$26.9M | -$17.4M | -$15.1M | -$11.1M | -$17.7M | -$13.4M | -$11.5M | -$9.4M | -$6.8M | -$8.1M | -$11.6M | -$5.7M | -$5.4M | |||||||||
| Income Tax Expense Benefit | -$30.0K | $37.0K | $34.0K | $15.0K | $18.0K | $19.0K | $26.0K | $15.0K | $4.0K | -$13.0K | $4.0K | $23.0K | $2.0K | $6.0K | $6.0K | $0.00 | $0.00 | $148.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$29.8M | -$25.7M | $316.0K | -$36.7M | $90.9M | -$51.7M | -$2.3M | -$55.7M | -$24.0M | -$21.6M | -$21.2M | -$21.9M | -$20.2M | -$19.6M | -$18.7M | -$17.4M | -$15.1M | -$11.0M | -$17.7M | -$13.4M | -$10.9M | |||||||||
| Non Cash Interest Expense | $225.0K | $254.0K | $225.0K | $198.0K | $178.0K | $119.0K | $153.0K | $27.0K | $941.0K | |||||||||||||||||||||
| Research And Development Incentive Receivable | $715.0K | $720.0K | $665.0K | $1.1M | $854.0K | $702.0K | $393.0K | $820.0K | $658.0K | $909.0K | $843.0K | $868.0K | $646.0K | $1.1M | $768.0K | $629.0K | $509.0K | $416.0K | $1.7M | $1.7M | $1.6M | |||||||||
| Comprehensive Income Net Of Tax | -$17.4M | -$15.1M | -$11.1M | -$17.8M | -$13.4M | -$10.9M | -$8.6M | -$6.0M | -$7.4M | -$11.8M | -$6.0M | -$5.5M | ||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $0.00 | $0.00 | $0.00 | -$77.0K | -$65.0K | $23.0K | $0.00 | $270.0K | $0.00 | -$212.0K | -$297.0K | -$82.0K | ||||||||||||||||||
| Cost Of Revenue | $351.0K | $326.0K | $4.7M | $227.0K | $268.0K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $186.3M | $22.1M | $51.1M | $74.1M | $64.4M | $72.8M | $129.2M | -$77.1M | -$44.5M | -$23.1M | -$34.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $217.9M | $56.5M | $100.2M | $123.0M | $83.1M | $80.7M | $128.1M | $8.5M | $27.0M | $15.3M | $7.1M |
| Cash And Cash Equivalents At Carrying Value | $217.0M | $55.7M | $99.2M | $121.7M | $81.8M | $78.7M | $126.2M | $8.1M | $26.7M | $15.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $161.4M | -$43.8M | -$22.8M | $39.9M | $2.4M | -$47.4M | $119.6M | -$18.6M | $11.7M | -$3.7M | |
| Retained Earnings Accumulated Deficit | -$594.6M | -$515.4M | -$477.9M | -$376.7M | -$282.9M | -$194.2M | -$132.0M | -$79.2M | -$92.3M | ||
| Property Plant And Equipment Net | $182.0K | $776.0K | $745.0K | $1.1M | $1.5M | $1.2M | $403.0K | $241.0K | $421.0K | ||
| Prepaid Expense And Other Assets Current | $3.5M | $5.6M | $7.3M | $5.8M | $5.3M | $3.7M | $1.1M | $1.2M | $1.1M | ||
| Other Liabilities Noncurrent | $525.0K | $831.0K | $432.0K | $173.0K | $826.0K | $462.0K | $16.0K | $205.0K | $9.0K | ||
| Liabilities Current | $25.8M | $32.9M | $22.9M | $22.3M | $14.0M | $11.9M | $9.4M | $7.9M | $10.7M | ||
| Liabilities And Stockholders Equity | $290.5M | $146.4M | $147.3M | $155.6M | $117.2M | $122.9M | $160.7M | $9.9M | $81.3M | ||
| Liabilities | $104.2M | $124.3M | $96.2M | $81.5M | $52.8M | $50.1M | $31.5M | $21.6M | $22.5M | ||
| Assets Current | $261.6M | $112.2M | $122.1M | $128.7M | $87.9M | $83.3M | $129.3M | $9.3M | $79.5M | ||
| Assets | $290.5M | $146.4M | $147.3M | $155.6M | $117.2M | $122.9M | $160.7M | $9.9M | $81.3M | ||
| Additional Paid In Capital Common Stock | $780.9M | $537.6M | $529.0M | $450.8M | $347.4M | $267.1M | $261.4M | $2.2M | $150.8M | ||
| Accrued Liabilities Current | $18.6M | $23.0M | $12.8M | $12.0M | $7.9M | $8.0M | $6.5M | $3.3M | $5.8M | ||
| Accounts Payable Current | $5.7M | $8.6M | $8.9M | $7.8M | $4.3M | $3.1M | $2.1M | $3.0M | $1.9M | ||
| Common Stock Value | $91.0K | $6.0K | $167.0K | $122.0K | $28.0K | $16.0K | $16.0K | $0.00 | $15.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$109.0K | -$122.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | $0.00 | $127.0K | ||
| Other Assets Noncurrent | $692.0K | $2.1M | $1.4M | $1.2M | $1.7M | $3.3M | $1.9M | $364.0K | $948.0K | ||
| Non Cash Lease Expense | $2.7M | $1.6M | $1.6M | $1.5M | $1.4M | $879.0K | $569.0K | $0.00 | $0.00 | ||
| Goodwill | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $27.1M | $27.1M | $0.00 | |||
| Temporary Equity Repurchase Of Convertible Preferred Stock | -$13.0K | $3.0K | $0.00 | $2.5M | $13.9M | $0.00 | $0.00 | $22.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $1.4M | $4.1M | $5.7M | $7.2M | $8.7M | $8.0M | $2.0M | ||||
| Operating Lease Liability Noncurrent | $0.00 | $1.4M | $2.6M | $3.6M | $4.8M | $4.5M | $1.9M | ||||
| Operating Lease Liability Current | $994.0K | $1.3M | $1.1M | $1.2M | $1.1M | $786.0K | $898.0K | ||||
| Repayments Of Long Term Debt | $0.00 | $0.00 | $2.1M | $795.0K | $0.00 | $0.00 | $9.4M | $6.4M | $0.00 | $250.0K | |
| Long Term Debt Non Current Including Accretion | $76.3M | $75.4M | |||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | -$162.0K | -$566.0K | -$229.0K | $0.00 | -$35.0K | ||||
| Change In Fair Value Of Convertible Preferred Stock Warrant Liability | -$12.8M | -$1.9M | -$7.1M | $2.9M | $366.0K | $437.0K | $105.0K | $3.5M | -$1.3M | ||
| Gain Loss On Disposition Of Intangible Assets | $0.00 | $105.0M | $0.00 | $0.00 | $0.00 | $0.00 | -$3.9M | $0.00 | $0.00 | ||
| Temporary Equity Dividends Adjustment | $0.00 | $0.00 | $592.0K | $3.0M | $3.0M | ||||||
| Long Term Debt Current | $0.00 | $1.3M | $795.0K | $0.00 | $0.00 | $1.7M | |||||
| Gain Loss On Disposition Of Assets1 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $61.6M | $4.0M | $22.9M | $59.6M | $94.5M | $1.0M | $67.6M | $67.5M | $51.7M | $61.8M | $30.1M | $49.7M | $68.7M | $87.3M | $105.1M | $89.7M | $104.9M | $118.8M | $79.1M | $96.2M | $29.4M | -$66.1M | -$57.7M | -$51.8M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $70.4M | $40.0M | $41.0M | $98.2M | $148.0M | $61.3M | $132.6M | $137.5M | $94.4M | $81.1M | $48.7M | $67.7M | $77.7M | $96.5M | $116.7M | $90.7M | $105.6M | $117.0M | $77.0M | $95.6M | $23.2M | $10.2M | $12.9M | $19.2M | $31.7M | $32.8M | $4.2M | ||||||
| Cash And Cash Equivalents At Carrying Value | $69.6M | $39.2M | $40.3M | $97.4M | $147.2M | $60.5M | $131.6M | $136.4M | $93.4M | $79.9M | $47.4M | $66.4M | $76.4M | $95.2M | $114.9M | $88.8M | $103.7M | $115.1M | $76.3M | $90.2M | $22.3M | $9.8M | $12.6M | $64.0M | $26.3M | $24.1M | $2.3M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$15.4M | -$39.0M | -$28.6M | -$15.4M | $36.0M | -$11.1M | $14.7M | -$7.8M | $820.0K | ||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$570.6M | -$540.8M | -$515.1M | -$475.5M | -$438.8M | -$529.7M | -$458.8M | -$456.5M | -$400.8M | -$347.6M | -$326.0M | -$304.8M | -$252.7M | -$232.5M | -$212.9M | -$175.8M | -$158.3M | -$143.2M | -$121.2M | -$103.5M | -$90.1M | -$125.9M | -$115.0M | -$102.9M | |||||||||
| Property Plant And Equipment Net | $218.0K | $254.0K | $487.0K | $820.0K | $808.0K | $742.0K | $772.0K | $868.0K | $986.0K | $1.2M | $1.3M | $1.4M | $1.6M | $1.7M | $1.8M | $1.3M | $421.0K | $475.0K | $348.0K | $258.0K | $271.0K | $323.0K | $353.0K | $384.0K | |||||||||
| Prepaid Expense And Other Assets Current | $4.9M | $5.0M | $4.5M | $4.5M | $5.0M | $5.8M | $5.8M | $5.5M | $4.2M | $5.0M | $4.4M | $3.6M | $3.7M | $5.2M | $4.2M | $4.5M | $5.6M | $3.5M | $1.2M | $1.6M | $2.4M | $1.3M | $4.4M | $2.5M | |||||||||
| Other Liabilities Noncurrent | $525.0K | $535.0K | $567.0K | $1.2M | $979.0K | $1.0M | $1.1M | $1.5M | $350.0K | $312.0K | $314.0K | $650.0K | $496.0K | $434.0K | $491.0K | $25.0K | $26.0K | $26.0K | $18.0K | $18.0K | $18.0K | $6.0K | $7.0K | $7.0K | |||||||||
| Liabilities Current | $23.5M | $22.9M | $25.9M | $29.3M | $28.9M | $23.5M | $25.4M | $22.3M | $19.5M | $28.7M | $22.0M | $15.0M | $13.2M | $13.1M | $14.7M | $13.2M | $10.8M | $8.0M | $8.3M | $13.2M | $16.5M | $8.9M | $10.2M | $9.3M | |||||||||
| Liabilities And Stockholders Equity | $163.6M | $105.2M | $130.0M | $178.2M | $210.6M | $112.2M | $173.3M | $173.4M | $124.4M | $113.4M | $81.0M | $99.6M | $120.5M | $141.7M | $161.0M | $133.1M | $142.5M | $153.7M | $109.5M | $133.5M | $62.5M | $45.9M | $57.2M | $69.2M | |||||||||
| Liabilities | $101.9M | $101.2M | $107.1M | $118.5M | $116.2M | $111.1M | $105.7M | $105.9M | $72.7M | $51.6M | $50.9M | $49.9M | $51.8M | $52.4M | $54.1M | $43.4M | $37.7M | $34.9M | $30.4M | $37.3M | $33.1M | $18.0M | $19.4M | $20.8M | |||||||||
| Assets Current | $132.8M | $72.9M | $95.7M | $143.0M | $175.4M | $87.3M | $147.9M | $147.6M | $98.2M | $85.7M | $52.6M | $70.9M | $80.7M | $101.4M | $120.0M | $93.9M | $109.9M | $122.0M | $79.2M | $96.6M | $26.2M | $44.9M | $56.6M | $68.5M | |||||||||
| Assets | $163.6M | $105.2M | $130.0M | $178.2M | $210.6M | $112.2M | $173.3M | $173.4M | $124.4M | $113.4M | $81.0M | $99.6M | $120.5M | $141.7M | $161.0M | $133.1M | $142.5M | $153.7M | $109.5M | $133.5M | $62.5M | $45.9M | $57.2M | $69.2M | |||||||||
| Additional Paid In Capital Common Stock | $632.3M | $544.9M | $538.1M | $535.1M | $533.3M | $530.7M | $526.3M | $524.0M | $452.4M | $409.5M | $356.2M | $354.6M | $321.4M | $319.9M | $318.0M | $265.6M | $263.3M | $262.1M | $200.4M | $199.7M | $119.5M | $153.7M | $152.6M | $151.4M | |||||||||
| Accrued Liabilities Current | $16.7M | $13.1M | $12.6M | $19.5M | $19.7M | $13.5M | $16.2M | $15.2M | $11.8M | $9.1M | $8.6M | $6.9M | $9.1M | $9.6M | $10.7M | $8.5M | $8.0M | $5.8M | $5.7M | $5.1M | $4.2M | $3.1M | $3.9M | $5.1M | |||||||||
| Accounts Payable Current | $5.1M | $7.7M | $11.1M | $8.6M | $8.0M | $8.9M | $8.1M | $5.1M | $6.0M | $3.8M | $3.7M | $3.6M | $2.4M | $2.5M | $3.1M | $3.9M | $1.8M | $1.2M | $1.7M | $3.1M | $6.1M | $2.1M | $2.1M | $1.1M | |||||||||
| Common Stock Value | $25.0K | $8.0K | $6.0K | $168.0K | $168.0K | $168.0K | $165.0K | $164.0K | $122.0K | $69.0K | $31.0K | $31.0K | $25.0K | $25.0K | $24.0K | $16.0K | $16.0K | $16.0K | $12.0K | $13.0K | $7.0K | $14.0K | $14.0K | $15.0K | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$118.0K | -$138.0K | -$128.0K | -$114.0K | -$159.0K | -$155.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$119.0K | -$42.0K | $23.0K | $144.0K | $177.0K | -$93.0K | |||||||||
| Other Assets Noncurrent | $2.0M | $2.4M | $3.0M | $2.4M | $1.8M | $1.5M | $1.2M | $1.1M | $1.0M | $1.5M | $1.8M | $1.6M | $2.0M | $2.0M | $2.4M | $2.5M | $3.5M | $2.4M | $106.0K | $96.0K | $101.0K | ||||||||||||
| Non Cash Lease Expense | $413.0K | $386.0K | $385.0K | $366.0K | $314.0K | $158.0K | $119.0K | ||||||||||||||||||||||||||
| Goodwill | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $27.1M | $27.1M | $27.1M | $27.1M | $27.1M | $27.1M | $27.1M | $27.1M | $27.4M | ||||||||||||
| Temporary Equity Repurchase Of Convertible Preferred Stock | -$20.0K | $10.0K | $6.0K | -$45.0K | $6.0K | $36.0K | $0.00 | $0.00 | $0.00 | $287.0K | $0.00 | $2.3M | $0.00 | $0.00 | $22.0K | $22.0K | |||||||||||||||||
| Operating Lease Right Of Use Asset | $1.8M | $2.6M | $3.7M | $4.5M | $4.9M | $5.3M | $6.1M | $6.5M | $6.8M | $7.6M | $8.0M | $8.3M | $9.1M | $9.4M | $9.8M | $8.2M | $1.6M | $1.8M | $2.1M | $2.2M | $2.7M | ||||||||||||
| Operating Lease Liability Noncurrent | $95.0K | $815.0K | $1.1M | $1.8M | $2.0M | $2.3M | $2.8M | $3.1M | $3.4M | $3.8M | $4.1M | $4.5M | $5.1M | $5.4M | $5.6M | $4.7M | $1.4M | $1.7M | $2.1M | $2.4M | $3.3M | ||||||||||||
| Operating Lease Liability Current | $1.2M | $1.4M | $1.3M | $1.2M | $1.2M | $1.1M | $1.1M | $1.1M | $1.2M | $1.2M | $1.1M | $1.1M | $1.0M | $985.0K | $875.0K | $756.0K | $940.0K | $916.0K | $878.0K | $860.0K | $841.0K | ||||||||||||
| Repayments Of Long Term Debt | $500.0K | $582.0K | |||||||||||||||||||||||||||||||
| Long Term Debt Non Current Including Accretion | $76.1M | $75.8M | $75.6M | $75.2M | $75.0M | $54.8M | $54.6M | $54.3M | $31.8M | $31.8M | $32.3M | $18.7M | $24.5M | $29.8M | $33.1M | $33.0M | $33.5M | $33.4M | $33.2M | $25.5M | $25.4M | $25.3M | $20.1M | $20.0M | $21.7M | $13.4M | $8.1M | ||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$162.0K | -$566.0K | $0.00 | $0.00 | $0.00 | -$462.0K | ||||||||||||||||||||||
| Change In Fair Value Of Convertible Preferred Stock Warrant Liability | -$10.8M | $13.8M | $0.00 | $288.0K | $592.0K | ||||||||||||||||||||||||||||
| Gain Loss On Disposition Of Intangible Assets | $0.00 | $0.00 | $0.00 | $105.0M | $0.00 | -$4.0M | $0.00 | ||||||||||||||||||||||||||
| Temporary Equity Dividends Adjustment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $592.0K | $756.0K | $748.0K | $740.0K | ||||||||||||||||||||||||
| Long Term Debt Current | $0.00 | $764.0K | $554.0K | $14.6M | $8.6M | $3.4M | $693.0K | $0.00 | $4.2M | $5.3M | |||||||||||||||||||||||
| Gain Loss On Disposition Of Assets1 | $0.00 | $105.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $509.0K | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $238.6M | $20.3M | $88.5M | $117.2M | $74.2M | $12.4M | $140.7M | $6.9M | $33.4M | $18.1M |
| Investing Cash Flow * | $8.2M | $67.0M | -$14.9M | -$103.0K | -$615.0K | -$1.4M | $27.2M | $0.00 | -$378.0K | -$73.0K |
| Operating Cash Flow * | -$85.6M | -$130.9M | -$96.5M | -$77.1M | -$70.9M | -$58.8M | -$48.1M | -$25.4M | -$21.3M | -$21.6M |
| Share Based Compensation | $4.3M | $8.2M | $8.7M | $5.2M | $6.2M | $5.4M | $2.1M | $759.0K | $492.0K | $644.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$4.2M | -$683.0K | $1.4M | $610.0K | $1.8M | $1.7M | -$109.0K | -$279.0K | -$402.0K | $2.2M |
| Increase Decrease In Accrued Liabilities | -$2.0M | $7.2M | $1.6M | $3.8M | -$152.0K | $1.5M | $160.0K | $1.5M | $1.4M | $521.0K |
| Increase Decrease In Accounts Payable | -$3.0M | -$286.0K | $1.2M | $3.4M | $1.2M | $1.0M | -$2.8M | $1.3M | -$1.2M | $1.3M |
| Depreciation Depletion And Amortization | $1.3M | $796.0K | $419.0K | $513.0K | $499.0K | $351.0K | $103.0K | $103.0K | $71.0K | $285.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $213.0K | -$156.0K | $99.0K | -$105.0K | -$319.0K | $402.0K | -$250.0K | $0.00 | $0.00 | -$103.0K |
| Payments To Acquire Productive Assets | $0.00 | $326.0K | $60.0K | $103.0K | $615.0K | $1.4M | $174.0K | $0.00 | $378.0K | $73.0K |
| Increase Decrease In Lease Liabilities | -$1.7M | -$1.0M | -$1.1M | -$882.0K | -$698.0K | -$1.1M | -$753.0K | $0.00 | $0.00 | |
| Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs | $0.00 | $60.0M | $122.6M | $76.0M | -$277.0K | $139.4M | $0.00 | $0.00 | ||
| Proceeds From Exercise Of Stock Options And Warrants | $294.0K | $8.7M | $208.0K | $260.0K | $561.0K | $792.0K | $7.0K | $9.0K | ||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $0.00 | $12.0K | $0.00 | $278.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $0.00 | $0.00 | -$2.1M | $5.0M | $55.0M | $5.0M | $113.0K | -$1.7M | $4.3M | |||
| Investing Cash Flow * | -$3.1M | -$5.3M | -$9.0K | -$22.0K | -$496.0K | -$555.0K | $26.4M | -$17.0K | ||||
| Operating Cash Flow * | -$12.4M | -$63.9M | -$33.6M | -$68.8M | -$47.9M | -$26.5M | -$20.2M | -$18.4M | -$15.5M | -$11.8M | -$6.2M | -$3.5M |
| Share Based Compensation | $519.0K | $1.7M | $1.6M | $1.5M | $1.3M | $613.0K | $262.0K | $128.0K | $182.0K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$201.0K | -$1.1M | -$2.1M | -$1.6M | $711.0K | $869.0K | $595.0K | -$170.0K | $2.0M | |||
| Increase Decrease In Accrued Liabilities | -$7.8M | $1.3M | $496.0K | -$984.0K | -$786.0K | -$668.0K | -$2.1M | $240.0K | $1.1M | |||
| Increase Decrease In Accounts Payable | $2.5M | $4.0K | -$1.7M | -$713.0K | -$23.0K | -$800.0K | $1.3M | -$563.0K | $1.3M | |||
| Depreciation Depletion And Amortization | $476.0K | $62.0K | $127.0K | $133.0K | $106.0K | $36.0K | $20.0K | $26.0K | $48.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $72.0K | -$59.0K | $50.0K | -$69.0K | -$143.0K | -$34.0K | -$21.0K | $17.0K | $12.0K | |||
| Payments To Acquire Productive Assets | $0.00 | $59.0K | $9.0K | $22.0K | $496.0K | $555.0K | $0.00 | $17.0K | ||||
| Increase Decrease In Lease Liabilities | -$274.0K | -$240.0K | -$250.0K | -$236.0K | -$160.0K | -$210.0K | -$201.0K | |||||
| Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs | $0.00 | -$443.0K | $5.9M | $55.0M | $0.00 | |||||||
| Proceeds From Exercise Of Stock Options And Warrants | $0.00 | $41.0K | $96.0K | $113.0K | ||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $12.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.87 | -$5.59 | -$17.07 | -$1.52 | -$3.99 | -$3.09 | -$4.63 | -$79.15 | -$54.58 | -$44.79 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 90.9M | 5.7M | 167.4M | 121.7M | 28.1M | 16.3M | 16.1M | 351.7K | 14.3M | |
| Common Stock Shares Issued | 90.9M | 5.7M | 167.4M | 121.7M | 28.1M | 16.3M | 16.1M | 351.7K | 14.3M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 25.7M | 20.1M | 11.5M | 459.0K | 458.0K | 513.5K | ||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 125.0M | 125.0M | 125.0M | 33.3M | 11.1M | 200.0M | ||
| Weighted Average Number Of Shares Outstanding Basic | 42.3M | 6.7M | 5.9M | 63.5M | 25.7M | 20.1M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 42.3M | 6.7M | 5.9M | 63.5M | 25.7M | 20.1M | ||||
| Earnings Per Share Basic | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.69 | -$3.47 | $0.04 | -$5.48 | $13.57 | -$7.77 | -$0.01 | -$0.33 | -$0.16 | -$0.26 | -$0.60 | -$0.72 | -$0.76 | -$0.74 | -$1.30 | -$0.87 | -$0.76 | -$0.56 | -$1.22 | -$1.02 | -$6.67 | -$0.65 | -$20.39 | -$14.83 | -$17.70 | -$1.68 | -$22.60 | -$11.13 | -$10.49 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Shares Outstanding | 25.1M | 8.0M | 5.8M | 168.5M | 168.2M | 167.9M | 164.7M | 164.4M | 122.2M | 68.7M | 31.0M | 30.8M | 24.7M | 24.6M | 23.4M | 16.3M | 16.1M | 12.4M | 12.4M | 6.7M | 14.3M | 14.3M | 14.3M | |||||||
| Common Stock Shares Issued | 25.1M | 8.0M | 5.8M | 168.5M | 168.2M | 167.9M | 164.7M | 164.4M | 122.2M | 68.7M | 31.0M | 30.8M | 24.7M | 24.6M | 23.4M | 16.3M | 16.2M | 16.1M | 12.4M | 12.4M | 6.7M | 14.3M | 14.3M | 14.3M | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 35.4M | 33.7M | 26.6M | 26.5M | 20.8M | 20.1M | 20.0M | 20.0M | 14.6M | 13.2M | 1.7M | 459.0K | 458.7K | 458.0K | 513.9K | 513.9K | 513.9K | |||||||||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 33.3M | 33.3M | 33.3M | 33.3M | 200.0M | 200.0M | 200.0M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 43.3M | 7.4M | 6.8M | 6.7M | 6.7M | 6.7M | 197.0M | 168.7M | 146.0M | 83.2M | 35.4M | 33.7M | 26.6M | |||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 43.3M | 7.4M | 6.9M | 6.7M | 6.7M | 6.7M | 197.0M | 168.7M | 146.0M | 83.2M | 35.4M | 33.7M | 26.6M | |||||||||||||||||
| Earnings Per Share Basic | $-0.69 | $-3.47 | $0.04 | $-5.48 | $13.59 | $-7.77 | $-0.01 | $-0.33 | $-0.16 | $-0.26 | $-0.60 | $-0.72 | $-0.76 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.3M | $8.2M | $8.7M | $5.2M | $6.2M | $5.4M | $2.1M | $759.0K | $492.0K | $644.0K |
| Investment Income Interest | $4.6M | $5.8M | $4.6M | $219.0K | $10.0K | $273.0K | $1.2M | $236.0K | $64.0K | |
| Derivative Gain Loss On Derivative Net | $12.8M | $1.9M | $7.1M | $1.7M | -$366.0K | -$437.0K | $183.0K | -$89.0K | -$94.0K | $1.4M |
| Other Noncash Income Expense | $161.0K | $639.0K | $227.0K | -$37.0K | -$337.0K | $413.0K | $0.00 | $0.00 | ||
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $288.0K | $3.4M | -$1.4M | -$39.0K | ||||
| Stock Issued During Period Value Stock Options Exercised | $40.0K | $127.0K | $345.0K | $7.0K | $9.0K | |||||
| Stock Issued During Period Value New Issues | $238.9M | $60.4M | $59.4M | $73.9M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $760.0K | $748.0K | $519.0K | $1.8M | $2.4M | $1.7M | $2.4M | $2.1M | $1.6M | $1.1M | $1.5M | $1.5M | $1.5M | $1.8M | $1.3M | $2.2M | $1.2M | $613.0K | $691.0K | $433.0K | $262.0K | $198.0K | $145.0K | $128.0K | |||
| Investment Income Interest | $901.0K | $665.0K | $1.0M | $1.9M | $1.6M | $1.1M | $1.4M | $914.0K | $835.0K | $14.0K | $4.0K | $3.0K | $2.0K | $3.0K | $2.0K | $0.00 | $7.0K | $296.0K | $464.0K | $394.0K | $69.0K | $51.0K | $67.0K | $69.0K | $90.0K | ||
| Derivative Gain Loss On Derivative Net | -$676.0K | $2.6M | $10.8M | -$1.9M | $20.2M | -$13.8M | $25.2M | $5.4M | $0.00 | $335.0K | $176.0K | -$62.0K | $57.0K | -$31.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $183.0K | -$5.0K | $159.0K | -$565.0K | $762.0K | |||
| Other Noncash Income Expense | $173.0K | $117.0K | $51.0K | $120.0K | -$99.0K | -$70.0K | $0.00 | ||||||||||||||||||||
| Fair Value Adjustment Of Warrants | $13.8M | -$5.4M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $288.0K | -$45.0K | -$283.0K | $592.0K | -$5.0K | -$11.0K | |||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $2.0K | $8.8M | $40.0K | $29.0K | $2.0K | $96.0K | $40.0K | $5.0K | $113.0K | $7.0K | |||||||||||||||||
| Stock Issued During Period Value New Issues | $86.7M | $6.0M | $60.4M | $13.5M | $49.0K | $5.8M | $49.6M | $79.3M | $0.00 |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.